Search
AZD-3839
go.drugbank.com/drugs/DB12368InvestigationalAZD3839 has been used in trials studying the basic science of Safety, Tolerability, Alzheimer's Disease, and Blood Concentration.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingTecemotide
go.drugbank.com/drugs/DB12568InvestigationalTecemotide has been used in trials studying the treatment of Prostate Cancer and Carcinoma, Non-Small-Cell Lung.
AZD-3043
go.drugbank.com/drugs/DB12576InvestigationalAZD3043 has been used in trials studying the treatment and basic science of Safety, Sedation, Tolerability, and Pharmacokinetics.
JNJ-41443532
go.drugbank.com/drugs/DB12632InvestigationalJNJ-41443532 has been used in trials studying the basic science and treatment of Diabetes Mellitus, Type 2.
Categories: Heterocyclic Compounds, 1-RingSamalizumab
go.drugbank.com/drugs/DB12636InvestigationalSamalizumab has been used in trials studying the treatment of Multiple Myeloma and B-cell Chronic Lymphocytic Leukemia.
Nelivaptan
go.drugbank.com/drugs/DB12643InvestigationalNelivaptan has been used in trials studying the treatment of Anxiety Disorders, Depressive Disorder, and Major Depressive Disorder.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingVTP-194204
go.drugbank.com/drugs/DB11806InvestigationalNrx194204 has been used in trials studying the treatment of Parkinson's Disease and Non-small Cell Lung Cancer.
Prothipendyl
go.drugbank.com/drugs/DB12958InvestigationalProthipendyl has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesAnumigilimab
go.drugbank.com/drugs/DB16359InvestigationalCSL324 is a fully human anti-G-CSFR antibody shown to have the ability to control G-CSF-mediated neutrophilia in cynomolgus macaques.
VLTS-589
go.drugbank.com/drugs/DB05430InvestigationalVLTS-589 consists of plasmid encoding the angiomatrix protein Del-1 in conjunction with poloxamer 188 for the treatment of peripheral vascular disease.